Back to ROYCE & ASSOCIATES LP ROYCE & ASSOCIATES LP

EGRXEGRX
Showing 2 of 24 quarters

Position history for ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP's holdings in EAGLE PHARMACEUTICALS INC

ROYCE & ASSOCIATES LP previously held 0 shares of EGRX (EAGLE PHARMACEUTICALS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$51,552

Total Shares Change

-13,821

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Unchanged
13,821
0.0%
$51,5520.0%$3.95
0

Other major holders of EGRX: BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used